Correction to: Efficacy, Safety, and Tolerability of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis.
Inflamm Bowel Dis
; 28(12): 1938, 2022 Dec 01.
Article
en En
| MEDLINE
| ID: mdl-35489068
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Año:
2022
Tipo del documento:
Article